The upgrade in the price target by a significant margin from $13 to $25 by Citigroup, a major financial institution, is a strong positive signal to the market. This action suggests a bullish outlook on Macrogenics by the analyst, which could lead to increased investor confidence and potentially drive the stock price up in the short term.